MammaPrint gives you a clear answer in breast cancer prognosis
"Gene expression profiling is a milestone in the prognosis of cancer. The expert panels’ statements at the international breast cancer conference show that MammaPrint will play an important role in future risk-management."
- PD Dr. Kunz, St. Johannes Hospital, Dortmund, Germany
“With the help of MammaPrint one-in-three patients can be saved from chemotherapy. This is a major relief to patients with good prognosis as chemotherapy is the most dreaded part of breast cancer therapy.”
- Prof. J. Apffelstaedt, Apffelstaedt & Associates, Cape Town, South Africa
|
Services & Products 